News
Halozyme Therapeutics (NASDAQ: HALO) shares fell sharply by 16% after Leerink Partners analyst David Risinger downgraded the stock from Market Perform to Underper ...
Bungie's co-founder demanded one scene stay in Halo 2, forcing writers to twist the plot. The hill he chose to die on?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback